Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

185 trials

NCT05962892
Recruiting
A Study of Factors Influencing Recurrence After Thermal Ablation of Papillary Thyroid Carcinoma
Not applicable · China · 1 site
Registry update: 30 Jan 2024
2022-503036-13-00
Recruiting
[18F]AlF-PSMA-11 PET in advanced thyroid and head and neck carcinoma
Phase 2 · Belgium · 1 site
Registry update: 7 Oct 2025
NCT06141369
Recruiting
Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001)
Not applicable · China · 1 site
Registry update: 9 Apr 2026
NCT06222606
Recruiting
Surgery for Thyroid Cancer With or Without Autofluorescence to Prevent Hypoparathyroidism
Not applicable · Denmark · 1 site
Registry update: 6 Oct 2025
NCT06158360
Recruiting
An Observational Study on Postoperative Symptoms After Thyroidectomy (POS-T)
Not applicable · South Korea · 3 sites
Registry update: 30 Mar 2026
NCT06359847
Recruiting
Study of ST-1898 in Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Cancer
Phase 2 · China · 1 site
Registry update: 5 Nov 2026
NCT06918223
Recruiting
Assessing Patient Satisfaction and Confidence After Use of Educational Video to Augment Surgical Consent for Thyroid Surgery
Not applicable · United States · 1 site
Registry update: 13 Apr 2025
NCT06277180
Recruiting
68Ga-TCR-FAPI PET/CT Guided Precision Surgery for MTC
Not applicable · China · 1 site
Registry update: 26 Feb 2024
NCT05999630
Recruiting
Artificial Tears to Prevent Nasolacrimal Duct Obstruction in Patients Treated With Radioactive Iodine for Thyroid Cancer
Phase 3 · United States · 1 site
Registry update: 3 Nov 2026
NCT06007924
Recruiting
A Study of Avutometinib and Defactinib in People With Thyroid Cancer
Phase 2 · United States · 7 sites
Registry update: 15 Oct 2026
NCT06835426
Recruiting
High-resolution PET-CT Specimen Imaging for the Perioperative Visualization of Resection Margins
Not applicable · Belgium · 1 site
Registry update: 19 Feb 2025
NCT05994365
Recruiting
Study of Anlotinib Hydrochloride Capsules in the Treatment of Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Carcinoma
Not applicable · China · 3 sites
Registry update: 16 Aug 2023
NCT06149637
Recruiting
Lateral Cervical Node Dissection in Differentiated Thyroid Cancer.
Not applicable · Colombia · 1 site
Registry update: 29 Oct 2024
NCT05830500
Recruiting
Study of Anlotinib in Patients With Advanced Medullary Thyroid Carcinoma
Phase 4 · China · 19 sites
Registry update: 25 Jul 2023
NCT06236373
Recruiting
The Unmet Needs of Cancer Survivors in Ausl IRCCS Reggio Emilia
Not applicable · Italy · 1 site
Registry update: 9 Dec 2024
NCT06929650
Recruiting
The Safety and Feasibility of Radiofrequency Ablation to Treat Low-risk Thyroid Cancer
Not applicable · Canada · 1 site
Registry update: 16 Apr 2025
NCT05786924
Recruiting
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Phase 1/2 · Australia, China, Denmark, Spain, France, United Kingdom, Hong Kong, Italy, Japan, United States · 49 sites
Registry update: 13 Oct 2026
NCT05837260
Recruiting
Investigating Utility of ctDNA and Tumour Evolution in Advanced Thyroid Cancer
Not applicable · United Kingdom · 1 site
Registry update: 9 Aug 2024
NCT06146764
Recruiting
CEUS Improves the Diagnostic Performance of SRSS of Thyroid Carcinoma
Not applicable · China · 1 site
Registry update: 23 Mar 2026
NCT06878534
Recruiting
Observational Study Analysing the Transcriptome and Mutational Status of Thyroid Carcinomas of Follicular Origin with Different Degrees of Malignancy
Not applicable · Italy · 1 site
Registry update: 17 Mar 2025

Ordered by registry start date. Freshness and sponsorship never change the order.